Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • People with epilepsy can benefit from smartphone apps to manage their condition

  • Bow ties and cuttlefish: New insight into a visual super sense

  • Sleep deprivation could reduce intrusive memories of traumatic scenes

  • Computer model shows how nerve cell connections form in visual cortex

  • Males may contribute to offspring's mental development before pregnancy

  • Warts and all: How St. John's Wort can make you sick

  • Hospital-wide program for delirium, alcohol withdrawal and suicide/harm impacts readmission rates

  • Causal pathway may link job stress, sleep disturbances

  • Women's faces get redder at ovulation, but human eyes can't pick up on it

  • Innovative imaging study shows that the spinal cord learns on its own

  •